Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
Abstract Background The rapidly developed vaccines against the severe acute respiratory syndrome coronavirus 2 carry a risk of provoking side effects. This study aimed to evaluate current vaccination non-serious/serious side effects. Methods A multicenter electronic questionnaire via an online platf...
Saved in:
Main Authors: | Behzad Houshmand (Author), Seied Omid Keyhan (Author), Hamid Reza Fallahi (Author), Shaqayeq Ramezanzade (Author), Erfan Sadeghi (Author), Parisa Yousefi (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SG-APSIC1049: Immunogenicity of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in seropositive and seronegative adults
by: Igor Stoma, et al.
Published: (2023) -
Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy
by: Donya Hatami, et al.
Published: (2024) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.
by: Chandima Jeewandara, et al.
Published: (2022) -
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka
by: Chandima Jeewandara, et al.
Published: (2022) -
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
by: Yaowen Zhang, et al.
Published: (2022)